Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-07-11 @ 4:49 AM
Study NCT ID:
NCT02588833
Status:
COMPLETED
Last Update Posted:
2021-01-11
First Post:
2015-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Paroxysmal Nocturnal Hemoglobinuria | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | PNH | View |
| None | Paroxysmal Nocturnal Hemoglobinuria | View |
| None | Complement inhibitor | View |
| None | Anemia | View |
| None | Hemoglobinuria | View |
| None | Hemolysis | View |
| None | Hematologic diseases | View |
| None | Extravascular hemolysis (EVH) | View |
| None | Intravascular hemolysis (IVH) | View |
| None | C3 inhibitor | View |